Clinical Trial Update: Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for sevuparin infusion in managing acute vaso-occlusive crises in sickle cell disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• sevuparin (sevuparin)

Snippet

Sponsor: Modus Therapeutics AB | Conditions: Sickle-Cell Disease | Phase 2 | Status: COMPLETED